These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 21503567

  • 1. Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer.
    Shi P, Zhang Y, Tong X, Yang Y, Shao Z.
    Int J Mol Med; 2011 Jul; 28(1):109-14. PubMed ID: 21503567
    [Abstract] [Full Text] [Related]

  • 2. Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1) attributed to disruption of p27(Kip1)/Skp2 complex.
    Hsu JD, Kao SH, Ou TT, Chen YJ, Li YJ, Wang CJ.
    J Agric Food Chem; 2011 Mar 09; 59(5):1996-2003. PubMed ID: 21299246
    [Abstract] [Full Text] [Related]

  • 3. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA, Fernandes KM, Morrison RF.
    J Cell Physiol; 2007 Apr 09; 211(1):101-11. PubMed ID: 17096381
    [Abstract] [Full Text] [Related]

  • 4. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N, Yoshizawa K, Tsubura A.
    Oncol Rep; 2012 Jul 09; 28(1):105-10. PubMed ID: 22484732
    [Abstract] [Full Text] [Related]

  • 5. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M.
    Amino Acids; 2009 Jul 09; 37(2):257-62. PubMed ID: 18604603
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.
    Breast Cancer Res Treat; 2006 Sep 09; 99(2):185-91. PubMed ID: 16636894
    [Abstract] [Full Text] [Related]

  • 7. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
    Andreu EJ, Lledó E, Poch E, Ivorra C, Albero MP, Martínez-Climent JA, Montiel-Duarte C, Rifón J, Pérez-Calvo J, Arbona C, Prósper F, Pérez-Roger I.
    Cancer Res; 2005 Apr 15; 65(8):3264-72. PubMed ID: 15833859
    [Abstract] [Full Text] [Related]

  • 8. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul 15; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 9. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS.
    Cancer Res; 2008 May 01; 68(9):3379-88. PubMed ID: 18451165
    [Abstract] [Full Text] [Related]

  • 10. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, Gold LI.
    PLoS One; 2012 May 01; 7(9):e46072. PubMed ID: 23029392
    [Abstract] [Full Text] [Related]

  • 11. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 12. Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.
    Miyamoto T, Horiuchi A, Kashima H, Suzuki A, Yamada T, Kurai M, Konishi I, Shiozawa T.
    Gynecol Endocrinol; 2010 Mar 15; 26(3):220-9. PubMed ID: 19724954
    [Abstract] [Full Text] [Related]

  • 13. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH, Hendrayani SF, Aboussekhra A.
    Mol Cancer Res; 2011 Mar 15; 9(3):311-9. PubMed ID: 21270107
    [Abstract] [Full Text] [Related]

  • 14. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
    Lu JX, Wang YC, Shen AG, Zhao YM, Sun CL, Zhang DM, Cheng C.
    Zhonghua Zhong Liu Za Zhi; 2008 May 15; 30(5):330-4. PubMed ID: 18953829
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, Motti ML, Pasquinelli R, Agosti V, Robledo M, Fusco A, Viglietto G.
    Endocr Relat Cancer; 2007 Jun 15; 14(2):405-20. PubMed ID: 17639054
    [Abstract] [Full Text] [Related]

  • 16. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC, Way TD, Lin CL, Lin JK.
    Endocrinology; 2008 Dec 15; 149(12):5972-83. PubMed ID: 18719023
    [Abstract] [Full Text] [Related]

  • 17. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S, Raven JF, Koromilas AE.
    Mol Cancer Res; 2010 May 15; 8(5):798-805. PubMed ID: 20407011
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 15; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 15; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 20. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
    Hershko DD.
    Cancer; 2008 Apr 01; 112(7):1415-24. PubMed ID: 18260093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.